Figure 9
From: Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells
Tannic acid augments therapeutic efficacy of doxorubicin and docetaxel against prostate cancer cells. MTS proliferation assay was used to determine potential chemo-sensitization activity of TA in combination with FDA-approved chemotherapeutic agents (A) Doxorubicin and (B) Docetaxel demonstrating TA enhances the chemo-sensitivity ability of the drugs. Data presented as mean ± standard error of the mean (n = 3). *, **, and *** represent level of significance with P (<0.05, 0.01 and 0.001) with respect to control.
